Advertisement

Topics

Rubius Therapeutics Closes $120 Million Financing

07:00 EDT 21 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Highly Oversubscribed Financing from Leading Investors to Support the Development of Red-Cell Therapeutic-Based Treatments Rubius Therapeutics, a biotechnology company pioneering the development of a new class of extraordina...

Other Sources for this Article

Pure Communications, Inc.
Katie Engleman, 910-509-3977
kengleman@purecommunications.com

NEXT ARTICLE

More From BioPortfolio on "Rubius Therapeutics Closes $120 Million Financing"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...